Skip to main content

Table 2 Complete blood count and PT and aPTT of the healthy volunteers and patient groups

From: Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity

  Healthy volunteers Sepsis CTS-TXA Cirrhotic liver disease Pregnancy
Hb
(mmol/L)
9.0
(8.4–9.6)
6.0*
(5.6–6.3)
6.2*
(5.7–6.7)
7.7*
(7.2–8.4)
7.8*
(7.0–8.4)
Ht
(L/L)
0.43
(0.40–0.45)
0.29*
(0.27–0.31)
0.29*
(0.26–0.32)
0.38*
(0.34–0.39)
0.36*
(0.34–0.39)
PLT
(x109/L)
178
(139–212)
141
(95–213)
101*
(91–140)
99*
(62–136)
202
(127–234)
WBC
(x109/L)
6.4
(5.4–7.9)
20.1*
(11.5–25.3)
10.7*
(8.3–12.4)
5.0
(4.0–7.5)
10.7*
(9.3–11.7)
PT
(s)
10.5
(10.2–10.8)
11.5*
(10.7–12.1)
11.8*
(11.5–12.4)
13.3*
(13.0–13.5)
9.6*
(9.3–9.6)
aPTT
(s)
27
(26–27)
33.5*
(30–42.5)
30*
(28–33)
29*
(29–34)
25*
(23–25)
  1. Results are median (IQR); * p < 0.05 in comparison to healthy volunteers
  2. Hb Hemoglobin, Ht Hmatocrit, PLT Platelet count, WBC White blood cell count, PT Prothrombin time, aPTT Activated partial thromboplastin time IQR, Interquartile ranges, CTS-TXA, Cardiothoracic surgery patients using tranexamic acid